Ludivine S. Breger

Lund University, Lund, Skåne län, Sweden 
Parkinson, animal model, a-syn, viral vector
"Ludivine Breger"
Mean distance: 14.8 (cluster 11)


Sign in to add mentor
Stephen B. Dunnett grad student 2010-2013 Cardiff University
 (second superviser)
Emma L. Lane grad student 2010-2013 Cardiff University
 (Main superviser)
Anders Björklund post-doc 2015- Lund University
Cecilia Lundberg post-doc 2013-2015 Wallenberg Neuroscience Center, Lund University
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Quintino L, Avallone M, Brännstrom E, et al. (2018) GDNF-mediated rescue of the nigrostriatal system depends on the degree of degeneration. Gene Therapy
Quintino L, Namislo A, Davidsson M, et al. (2018) Destabilizing Domains Enable Long-Term and Inert Regulation of GDNF Expression in the Brain. Molecular Therapy. Methods & Clinical Development. 11: 29-39
Breger LS, Kienle K, Smith GA, et al. (2016) Influence of chronic L-DOPA treatment on immune response following allogeneic and xenogeneic graft in a rat model of Parkinson's disease. Brain, Behavior, and Immunity
Chtarto A, Humbert-Claude M, Bockstael O, et al. (2016) A regulatable AAV vector mediating GDNF biological effects at clinically-approved sub-antimicrobial doxycycline doses. Molecular Therapy. Methods & Clinical Development. 5: 16027
Breger LS, Lane EL. (2013) L-DOPA and graft-induced dyskinesia: different treatment, same story? Experimental Biology and Medicine (Maywood, N.J.). 238: 725-32
Breger LS, Dunnett SB, Lane EL. (2013) Comparison of rating scales used to evaluate L-DOPA-induced dyskinesia in the 6-OHDA lesioned rat. Neurobiology of Disease. 50: 142-50
Smith GA, Breger LS, Lane EL, et al. (2012) Pharmacological modulation of amphetamine-induced dyskinesia in transplanted hemi-parkinsonian rats. Neuropharmacology. 63: 818-28
See more...